Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
14 March 2025
Cancers | Feature Papers from the Second Half of 2024 in the “Molecular Cancer Biology” Section
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Molecular Cancer Biology” Section, which are listed below.
1. “Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer”by Iseult M. Browne and Alicia F. C. Okines
Cancers2024, 16(12), 2259; https://doi.org/10.3390/cancers16122259
Available online: https://www.mdpi.com/2072-6694/16/12/2259
2. “Glutamine Metabolism and Prostate Cancer”
by Holger H. H. Erb, Nikita Polishchuk, Oleh Stasyk, Uğur Kahya, Matthias M. Weigel and Anna Dubrovska
Cancers 2024, 16(16), 2871; https://doi.org/10.3390/cancers16162871
Available online: https://www.mdpi.com/2072-6694/16/16/2871
3. “Spheno-Orbital Meningiomas: The Rationale behind the Decision-Making Process of Treatment Strategy”
by Giuseppe Mariniello, Sergio Corvino, Giuseppe Corazzelli, Oreste de Divitiis, Giancarlo Fusco, Adriana Iuliano, Diego Strianese, Francesco Briganti and Andrea Elefante
Cancers 2024, 16(11), 2148; https://doi.org/10.3390/cancers16112148
Available online: https://www.mdpi.com/2072-6694/16/11/2148
4. “Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer”
by Tianhong Li, Weijie Ma and Ebaa Al-Obeidi
Cancers 2024, 16(13), 2350; https://doi.org/10.3390/cancers16132350
Available online: https://www.mdpi.com/2072-6694/16/13/2350
5. “Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review”
by Víctor Manuel Medina Pérez, Marta Baselga and Alberto J. Schuhmacher
Cancers 2024, 16(15), 2681; https://doi.org/10.3390/cancers16152681
Available online: https://www.mdpi.com/2072-6694/16/15/2681
6. “G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications”
by Yuchao Ni, Mingchen Shi, Liangliang Liu, Dong Lin, Hao Zeng, Christopher Ong and Yuzhuo Wang
Cancers 2024, 16(12), 2175; https://doi.org/10.3390/cancers16122175
Available online: https://www.mdpi.com/2072-6694/16/12/2175
7. “Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway”
by Tong Pan, Dong-Kun Xie, Juan Li, Yu-Jie Qiang, Song-Yuan Fan, Ting-Ting Wang, Yuan-Yuan Han, Jian Zang, Yang Yang, Jun-Long Zhao et al.
Cancers 2024, 16(14), 2500; https://doi.org/10.3390/cancers16142500
Available online: https://www.mdpi.com/2072-6694/16/14/2500
8. “LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p”
by Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He and Qin Feng
Cancers 2024, 16(14), 2594; https://doi.org/10.3390/cancers16142594
Available online: https://www.mdpi.com/2072-6694/16/14/2594
9. “Orally Ingested Micro- and Nano-Plastics: A Hidden Driver of Inflammatory Bowel Disease and Colorectal Cancer”
by Annalisa Bruno, Melania Dovizio, Cristina Milillo, Eleonora Aruffo, Mirko Pesce, Marco Gatta, Piero Chiacchiaretta, Piero Di Carlo and Patrizia Ballerini
Cancers 2024, 16(17), 3079; https://doi.org/10.3390/cancers16173079
Available online: https://www.mdpi.com/2072-6694/16/17/3079
10. “KRAS, a New Target for Precision Medicine in Colorectal Cancer?”
by Alice Boilève, Cristina Smolenschi, Aurélien Lambert, Valérie Boige, Matthieu Delaye, Géraldine M. Camilleri, Anthony Tarabay, Marine Valéry, Alina Fuerea, Thomas Pudlarz et al.
Cancers 2024, 16(20), 3455; https://doi.org/10.3390/cancers16203455
Available online: https://www.mdpi.com/2072-6694/16/20/3455
11. “Insights into Dysregulated Neurological Biomarkers in Cancer”
by Elisa Duranti and Chiara Villa
Cancers 2024, 16(15), 2680; https://doi.org/10.3390/cancers16152680
Available online: https://www.mdpi.com/2072-6694/16/15/2680
12. “CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma”
by Issa Ismail Issa, Hanne Due, Rasmus Froberg Brøndum, Vidthdyan Veeravakaran, Hulda Haraldsdóttir, Cathrine Sylvester, Asta Brogaard, Soniya Dhanjal, Bernhard Schmierer and Karen Dybkær
Cancers 2024, 16(13), 2437; https://doi.org/10.3390/cancers16132437
Available online: https://www.mdpi.com/2072-6694/16/13/2437
13. “Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities”
by Anne Menz, Julia Zerneke, Florian Viehweger, Seyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Ahmed Abdulwahab Bawahab, Christoph Fraune, Christian Bernreuther et al.
Cancers 2024, 16(13), 2425; https://doi.org/10.3390/cancers16132425
Available online: https://www.mdpi.com/2072-6694/16/13/2425
14. “FUCA1: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression”
by Die Hu, Naoya Kobayashi and Rieko Ohki
Cancers 2024, 16(15), 2753; https://doi.org/10.3390/cancers16152753
Available online: https://www.mdpi.com/2072-6694/16/15/2753
15. “Subependymal Giant Cell Astrocytoma: The Molecular Landscape and Treatment Advances”
by Emanuela Pucko, Dorota Sulejczak and Robert P. Ostrowski
Cancers 2024, 16(19), 3406; https://doi.org/10.3390/cancers16193406
Available online: https://www.mdpi.com/2072-6694/16/19/3406
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
